FDA Inspection 1042322 — Freddy Goldberg Eliaschewitz
The FDA completed an inspection of Freddy Goldberg Eliaschewitz on January 19, 2018 in Sao Paulo. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 19, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Sao Paulo (Brazil)
Additional Details
Clinical Investigator (CI)